No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 2.2x · 10Y median 2.5x · 17th percentile · as of Sep 11, 2026
Annualized revenue (TTM) · by quarter, last 16
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-09-23T22:45:54.236Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-09-23T22:45:54.236Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-09-23T22:45:54.236Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-09-23T22:45:54.236Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-09-23T22:45:54.236Z. Latest historical point 2026-09-11.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-09-23T22:45:54.236Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-23T22:45:54.236Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-23T22:45:54.236Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Kenvue Inc. (KVUE) stock was $17.67 as of Sep 23, 2026, 4:00 PM EDT, down 1.06% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -1.2% · 3-year avg -3.0%/yr
Kenvue Inc. functions as a global leader in the consumer health sector.
Household & Personal Products · Summit, NJ
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Nov 2, 2026
40 days away
EPS Estimate
0.28
Revenue Est.
$3.86B
Last Quarter Results
EPS
$0.31
vs Estimate
$0.32
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1KVUE | $33.93B | $17.67 | -1.06% | -1.19% | N/A | N/A | N/A |
| 2HSY | $34.16B | $168.45 | -0.01% | -3.77% | +2.35% | +8.66% | vs KVUE |
| 3KR | $35.31B | $57.64 | -1.57% | -11.05% | +8.84% | +8.62% | vs KVUE |
| 4KMB | $32.43B | $97.70 | -1.22% | -20.37% | -2.75% | +1.32% | vs KVUE |
| 5EL | $35.74B | $98.83 | -1.46% | +13.49% | -20.75% | +2.34% | vs KVUE |
| 6SYY | $36.89B | $77.14 | -1.94% | +5.60% | +4.42% | +8.02% | vs KVUE |
TTM
2.20
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$3.96B
vs Estimate
$3.97B
Consensus Rating
Based on 12 analysts
Average Price Target
$19.50
+10.4% upside
Low
$18.00
Current
$17.67
High
$23.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.27 | $0.29 | $0.33 | 6 |
| Quarter ending Dec 2026 | $0.25 | $0.26 | $0.27 | 6 |
| Quarter ending Mar 2027 | $0.32 | $0.33 | $0.34 | 4 |
| Quarter ending Jun 2027 | $0.32 | $0.32 | $0.33 | 4 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $1.05 | $1.18 | $1.26 | 8 |
| FY 2027 | $1.18 | $1.25 | $1.34 | 8 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $3.85B | $3.86B | $3.87B | 6 |
| Quarter ending Dec 2026 | $3.87B | $3.88B | $3.90B | 6 |
| Quarter ending Mar 2027 | $3.95B | $4.00B | $4.07B | 5 |
| Quarter ending Jun 2027 | $4.00B | $4.05B | $4.12B | 5 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 28, 2026, matching Key Metrics.
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $15.50B | $15.60B | $15.67B | 10 |
| FY 2027 | $15.84B | $15.97B | $16.20B | 10 |
